Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 16 Sep - Newspaper Publication - Dispatch of Notice of Postal Ballot
Source: Bse
Camlin Fine Sciences Limited (CAMLINFINE)
Small CapIndustrials stocks · Small cap · NSE
Camlin Fine Sciences Limited operates in Food & Feed Additives, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers.
₹91.61
-3.48 · -3.66%
Market cap ₹1,751 Cr
Data qualityFresh enough for analysisQuote updated 19 Oct, 03:31 pm ISTDetails
Quote19 Oct, 03:31 pm IST
Base fundamentals06 Oct 2026 · screener
Latest result16 Aug, 01:21 am IST
Score20 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags02 May 2026
Coverage13/14 · 93%
Valuation2026-07-20 · Rf 6.8% · Industrials P/E 26.2 (n=537)
Technical timing lens
Trend score and candlestick chart
36Bearishfull bear SMA stack · SMA20 -9.3% / mo · MACD + · near 52W low
Stock trend: 26
Sector RS: 50
Sector 3M: -6.3% vs Nifty 500 -5.6%
Industrials FPI tailwindNot confirmed
Latest mapped FPI equity flow was not positive. View sector evidence
Technical chart
CAMLINFINED candles · FIT view-28.1%Latest close ₹91.61 on 2026-10-19
Bar
-4.4%
RSI
42
MACD hist
0.61
52W pos
3%
2026-10-19O ₹95.80H ₹96.70L ₹90.80C ₹91.61Vol 5.0L sh
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context
Relative performance and chart statistics
Adjusted completed-session prices, rebased to 100
CAMLINFINENifty India ManufacturingNifty 500
- CAMLINFINE
- -26.1%
- Nifty 500
- -5.6%
- Nifty India Manufacturing
- -5.8%
- Vs Nifty 500
- -20.5 pp
Chart stats
19 Oct 2026- From 52W high
- -55.2%
- 52W range position
- 3%
- ATR (14)
- 4.5%
- Volume vs 20D
- 0.71x
- Avg traded value
- ₹6.1 Cr
- 20D price channel
- ₹88.2 - ₹102
₹204.6
₹88.2 - ₹204.6
₹4.1
Latest completed session
20-session average
43.1% annualized volatility
Research snapshot
What the evidence says now
Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend argues for patience, and recent execution is mixed.
Suggested next step
Research, do not rush
The evidence is not strongly aligned. Compare peers and wait for a cleaner setup.
U-Score
Legacy · OVERVALUED19
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Latest result
Average32
Revenue +27.4% · PAT NDF YoY
Technical
Bearish36
Price trend and sector-relative-strength timing.
Valuation
Legacy model-6467.6%
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Trust
Limited evidence60
Financial-only signal; management claim evidence is not sufficient yet.
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Financials
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Latest result
Quarter ended 30 Jun 2026
Average · 32/100margin compression · Rev +27% YoY · +22% QoQ
Filed 30 Jun 2026
Open results browser →| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹520 Cr | +27.4% | +22.4% |
| EBITDA | ₹9 Cr | -55.0% | -57.1% |
| Operating margin | 1.8% | -320 bps | -320 bps |
| PAT | ₹-34 Cr | NDF | -139.5% |
| PAT margin | -6.5% | -384 bps | -2678 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Fundamentals
Valuation
- P/E
- —
- P/B
- 1.68
- EV/EBITDA
- 15.54
- Market Cap
- 1751.00Cr
Profitability
- ROE
- 3.75%
- ROCE
- 4.78%
- ROA
- 0.04%
- Dividend Y
- —
Growth (CAGR)
- Revenue 5Y
- 8.00%
- EPS 5Y
- -6.00%
- Revenue 3Y
- 1.00%
- EPS 3Y
- -14.00%
Balance Sheet
- Debt/Equity
- 0.69
- Interest Coverage
- 1.15×
- Altman Z
- 2.51
- Book Value
- 54.20
Cash Flow
- FCF Yield
- 1.66%
- FCF Positive Y
- 4/5
- OCF
- 82.00 Cr
- EPS TTM
- 0.29
Shareholding
- Promoter Hold
- 48.03%
- Promoter Pledge
- 0.00%
- Momentum 52W
- 2%
Financial History
Updated 20/10/2026
Revenue
₹ CrLatest: 1,723+5.8% vs prev
Net Profit
₹ CrLatest: 24.0+115.2% vs prev
Return on Equity
%Latest: 2.3+113.2% vs prev
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Technicals
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Daily technical trend read
Mixed signalsSignals are conflicting — long-term trend down. RSI 42. Wait for confirmation.
- Price < SMA20 < SMA50 < SMA200 — full bearish stack.
- SMA20 falling (~10.2% over last month) — short-term momentum negative.
- RSI(14) at 42 — rising, no extreme reading.
- MACD above signal, histogram expanding — bullish momentum building.
- Within 5% of 52-week low — testing support.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
Nifty 500 leadership
Relative Strength & Trend Stage
9
RS percentile
Stage 4 Downtrend
1M return
-5.8%
3M return
-26.1%
6M return
-14.4%
1Y return
-53.0%
RS 1D
-2
RS 20D
+4
Sector rank
#2
Industry rank
#9
Stage evidence
- Price is 20.8% below the 30-week proxy.
- The 50-DMA is below the 30-week proxy and its slope is falling -4.9%.
- Both 3-month and 6-month returns are negative.
50-DMA
price below
200-DMA
price below
Sector
leading
Industry
leading
Relative-strength line vs Nifty 500 (base 100)
262 observations
19 Oct 2026Value 44.82-2.67%
RS vs Nifty 50045
Valuation & peers
U-Score 19 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies
Valuation & peers
U-Score 19 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies
OVERVALUED
Fundamental score breakdown
U band · OVERVALUEDValuation2/30
Growth3/25
Quality0/20
Balance Sheet5/15
Cash Flow5/10
Piotroski
5/9 (+3)
Penalties
1
Raw sum
19
Why this score?
Top U-Score contributors and drags from the latest stored fundamentals.
19/100 · legacy band OVERVALUED
Positive drivers
- Cash flow contributes 5/10 to the score.
- Balance sheet contributes 5/15 to the score.
- Growth contributes 3/25 to the score.
Main drags
- Fair-value margin of safety is negative at -6467.6%.
- Quality is weaker at 0/20; verify the latest quarterly trend.
- Valuation is weaker at 2/30; verify the latest quarterly trend.
Sector valuation model
Blended valuation: PE, EV/EBITDA, FCF yield, and balance-sheet checks
For this sector, IndiaPulse uses a blended lens rather than relying on a single valuation ratio.
Primary lens
PE, EV/EBITDA, margin of safety, and FCF yield together.
Secondary checks
ROE/ROCE, growth, cash conversion, leverage, promoter risk.
Main risk check
One cheap metric is not enough if quality or cash flow is weak.
PE
—
PB
1.7
EV/EBITDA
15.5
ROE
3.8%
ROCE
4.8%
FCF Yield
1.7%
Debt/Equity
0.7
MoS
-6467.6%
Score movement
Stored run vs live recompute
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
Stored run: 20 Oct 2026
v4.3-runtime-valuation
Final score
19
Previous: 19
Legacy U-Score band
OVERVALUED
Previous: OVERVALUED
Margin of safety
-6467.6%
Previous: -6467.6%
Score history
12 stored score snapshots. Latest stored move: +0 points.
20 Oct 2026
v4.3-runtime-valuation
19
19
19
19
19
19
19
19
19
19
19
19
Factor attribution
No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.
Modelled fair value
Graham Number
₹18.81
-387.1% MoS
Growth-justified P/E
4.8
Growth-justified Value
₹1.39
-6467.6% MoS
PEG
—
Comparable companies
Peers
Business-comparable peers in Industrials — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
OAL
Small
Oriental Aromatics Limited
Specialty Chemicals
match 136
16
326.0
0.5%
-49609%
OVERVALUED
IGPL
Small
IG Petrochemicals Limited
Specialty Chemicals
match 135
30
20.9
0.2%
-3623%
OVERVALUED
BHAGERIA
Small
Bhageria Industries Limited
Specialty Chemicals
match 134
28
23.0
7.0%
-421%
OVERVALUED
SHK
Small
S H Kelkar and Company Limited
Specialty Chemicals
match 134
31
40.3
3.7%
-707%
OVERVALUED
PAUSHAKLTD
Small
Paushak Limited
Specialty Chemicals
match 134
24
43.1
7.0%
-419%
OVERVALUED
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business, management & trust
Growth engines, risks, management commitments and evidence-backed delivery
Business and thesis
Issuer presentation review pending
Camlin Fine Sciences Limited operates in Food & Feed Additives, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers. The structured result feed currently covers the quarter ended 30 Jun 2026. Investor presentations and earnings-call PDFs will be added as issuer-backed evidence before management claims appear here.
Trust Score
60Limited evidence · low confidenceTrust Lite
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 28th percentile of the scored universe and 24th percentile within Industrials. Main check: financial discipline is weak at 30/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Computed 05 Sept 2026
management-trust-v1
123 docs text-extracted · 30 concalls text-extracted
Score band
Limited evidence
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
Relative rank
28th percentile
overall median 67 · Industrials: 24th pctile, median 68 · Small: 32nd pctile, median 66
Evidence depth
Financial-only
123 documents have extracted text, but claim history is not strong enough yet.
Claim delivery
Outcome history still building
0 claims extracted · No contradicted claim yet
How to read this Trust Score
Limited evidence · low confidenceWhat it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Acceptable, but check the weakest sub-score before increasing exposure.
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Forensic breakdown
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Promoter
70
acceptable · holding, pledge, alignment
Cash flow
77
strong · profit to cash conversion
Balance sheet
51
watch · leverage and solvency
Discipline
30
weak · capital discipline
Results
67
acceptable · quarterly consistency
Trust positives
- ▸Promoter pledge is zero.
- ▸FCF yield is positive at 1.5%.
- ▸4 years of positive FCF.
- ▸3/4 latest quarters had positive YoY revenue growth.
Trust risks
- ▸Promoter holding fell 1.1%.
- ▸Interest coverage is 1.1x.
- ▸ROCE is low at 4.8%.
- ▸ROE is low at 3.8%.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Continue researching Camlin Fine Sciences Limited
Important announcements & filings
Latest exchange and company disclosures found within the past two years.
Open source ↗
Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 19 Jul - Newspaper Publication - Dispatch of Notice of 33rd Annual General Meeting of the Company.
Source: Bse
Annual report
Reg. 34 (1) Annual Report. 18 Jul
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Newspaper Publication 15 Jul - Newspaper Publication pursuant to 33rd Annual General Meeting of the Company.
Source: Bse
Announcement
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 28 Jun
Source: Bse
Annual report
Annual Report 2026
Source: Bse
Annual report
Annual Report 2025
Source: Bse
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.